Fish Oils
-
Subject Areas on Research
- A comparison of the effectiveness of lipid-lowering therapy between HIV- and non-HIV-infected subjects with hyperlipidaemia.
- Acanthosis nigricans: a practical approach to evaluation and management.
- Aging and dietary modulation of elastase and interleukin-1 beta secretion.
- Combination drug therapy for combined hyperlipidemia.
- Dietary fish oil. Influence on lesion regression in the porcine model of atherosclerosis.
- Effect of dietary fish oil supplementation on eicosanoid production by rat renal allografts.
- Enteral High Fat-Polyunsaturated Fatty Acid Blend Alters the Pathogen Composition of the Intestinal Microbiome in Premature Infants with an Enterostomy.
- Enteral fish oil in critical illness: perspectives and systematic review.
- Evaluating daily exposure to polychlorinated biphenyls and polybrominated diphenyl ethers in fish oil supplements.
- Fish oil feeding modulates leukotriene production in murine lupus nephritis.
- Fish oil slows prostate cancer xenograft growth relative to other dietary fats and is associated with decreased mitochondrial and insulin pathway gene expression.
- Fish oil, blood vessels, and depression.
- Long-Chain Omega-3 Fatty Acid Supplements in Depressed Heart Failure Patients: Results of the OCEAN Trial.
- Long-chain omega-3 fatty acids regulate bovine whole-body protein metabolism by promoting muscle insulin signalling to the Akt-mTOR-S6K1 pathway and insulin sensitivity.
- Multi-omic profiles of hepatic metabolism in TPN-fed preterm pigs administered new generation lipid emulsions.
- Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: correlation with erythrocytes and response to supplementation.
- Phase II prospective randomized trial of a low-fat diet with fish oil supplementation in men undergoing radical prostatectomy.
- Phase II study of high-dose fish oil capsules for patients with cancer-related cachexia.
- Relation of fish oil supplementation to markers of atherothrombotic risk in patients with cardiovascular disease not receiving lipid-lowering therapy.
- Risk factors associated with plasma omega-3 fatty acid levels in patients with suspected coronary artery disease.